OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Medicines Discovery Catapult, a new UK center established to support innovative drug discovery, is inviting UK SMEs working in medicines to collaborate on high-resolution analysis. On offer is access to an atomic resolution Solid State NMR (SSNMR) at Medicines Discovery Catapult’s facility within the University of Warwick, along with world-leading scientific support, including data analysis and interpretation. Through this Call Medicines Discovery Catapult aims to provide atomic resolution of a compound, protein structure or complex and its dynamic interactions, which are not normally amenable to resolution by other approaches. UK-registered micro, small or medium-sized enterprises engaged in drug discovery and drug re-purposing are invited to apply by Thursday November 30. Dr Peter Simpson, Chief Scientific Officer of Medicines Discovery Catapult commented: “We’re looking for innovative, dynamic partners with technically feasible proposals that will bring about significant new advances. This is an excellent opportunity for a UK SME to accelerate their R&D.” For more information, visit
https://md.catapult.org.uk/news/call-for-collaboration-SSNMR